Cargando…
Human recombinant RNASET2: A potential anti-cancer drug
The roles of cell motility and angiogenetic processes in metastatic spread and tumor aggressiveness are well established and must be simultaneously targeted to maximize antitumor drug potency. This work evaluated the antitumorigenic capacities of human recombinant RNASET2 (hrRNASET2), a homologue of...
Autores principales: | Roiz, Levava, Smirnoff, Patricia, Lewin, Iris, Shoseyov, Oded, Schwartz, Betty |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789573/ https://www.ncbi.nlm.nih.gov/pubmed/27014725 |
Ejemplares similares
-
Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014) -
Human RNASET2 derivatives as potential anti-angiogenic agents: actin binding sequence identification and characterization
por: Nesiel-Nuttman, Liron, et al.
Publicado: (2014) -
Diagnostic and therapeutic potential of RNASET2 in Crohn’s disease: Disease-risk polymorphism modulates allelic-imbalance in expression and circulating protein levels and recombinant-RNASET2 attenuates pro-inflammatory cytokine secretion
por: Biener-Ramanujan, Eva, et al.
Publicado: (2022) -
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene
por: Acquati, Francesco, et al.
Publicado: (2019) -
Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase
por: Lualdi, Marta, et al.
Publicado: (2015)